Covid 19 vaccine

The Gulf Arab state, which has among the world's highest immunisation rates, was already providing the Pfizer-BioNTech vaccine for…

Takeda will focus its efforts on dengue, zika and pandemic vaccines

The High Commissioner was provided with a tour of the vaccine fill-finish facility which is currently contracted by the UK…

The target action date does not mean the approval will not happen before January, the US Food and Drug Administration's Acting…

The research, published in the ACS Infectious Diseases journal on Thursday, showed that vaccine formulations by IISc-incubated…

The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly…

Cumulatively, 11,78,70,724 people in the age group 18-44 years have received the first dose and 41,92,141 their second dose since…

COVID-19 vaccines based on mRNA technology dominate the 7MM in 2021 with a market share of 95.4 per cent and $9.5 billion in sales…

As per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the vaccine in India per year

The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September, RDIF said